Notícias Eton Pharmaceuticals Inc - ETON | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Eton Pharmaceuticals Inc (ETON)
Eton Pharmaceuticals Inc (ETON) Notícias

Eton Pharmaceuticals Inc (ETON)

14,62

-0,16

( -1,08% )

Atualizado: 15:02:45

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Form 8-K/A - Current report: [Amend]

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

Form 8-K - Current report

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Form 8-K - Current report

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

Form 8-K - Current report

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

Form 8-K - Current report

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Eton Pharmaceuticals

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições